FMO5 and endothelial dysfunction: Based on the literature and proprietary data, we suggested that MDA-modified LDL can stimulate the expression of LOX-1 receptor biosynthesis and NADPH oxidase in endotheliocytes, which contributes to the development of endothelial dysfunction.